mshivaiah, Author at Corcept Therapeutics - Page 2 of 2

About mshivaiah

This author has not written his bio yet.
But we are proud to say that mshivaiah contributed 14 entries already.

Entries by mshivaiah

BELLA: A Phase 2 Study of Relacorilant + Nab-Paclitaxel +/- Bevacizumab in Patients with Gynecologic Cancers

Lorusso et al. • 2026 • SGO

April 13, 2026

Final Overall Survival Results from the Phase 3 ROSELLA Trial: Relacorilant Plus Nab-Paclitaxel vs Nab-Paclitaxel Monotherapy in Patients with Platinum-Resistant Ovarian Cancer (GOG-3073, ENGOT-ov72, APGOT-Ov10, LACOG-0223, and ANZGOG-2221/2023)

Lorusso et al. • The Lancet • Olawaiye et al. • SGO • 2026

April 10, 2026

Prevalence and Clinical Impact of Hypercortisolism in Patients With Resistant Hypertension: Primary Results From the MOMENTUM Study

Bhatt et al. • 2026 • ACC.26

March 28, 2026

Efficacy and Safety of Relacorilant for the Treatment of Patients With Cushing’s Syndrome (GRACE): A Multicentre, Phase 3, Double-Blind, Placebo-Controlled, Randomised-Withdrawal Study

Pivonello • 2026 • The Lancet Diabetes & Endocrinology

February 20, 2026